Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Sarepta Sinks on Disappointing Gene-Therapy Study Results
By M. Corey Goldman
Jan 8, 2021 9:36 AM EST
INVESTING
Sarepta Sinks on Disappointing Gene-Therapy Study Results
By M. Corey Goldman
Jan 8, 2021 9:36 AM EST
PRESS RELEASES
Rocket Pharmaceuticals Announces Participation At The 39th Annual J.P. Morgan Healthcare Conference
By Business Wire
Jan 6, 2021 7:00 AM EST
PRESS RELEASES
Rocket Pharmaceuticals Prices Upsized Public Offering Of Common Stock
By Business Wire
Dec 9, 2020 11:32 PM EST
PRESS RELEASES
Rocket Pharmaceuticals Announces Proposed Public Offering Of Common Stock
By Business Wire
Dec 9, 2020 7:51 AM EST
PRESS RELEASES
Rocket Pharmaceuticals Announces Positive Gene Expression, Clinical Biomarker And Preliminary Functional Data From Phase 1 Trial Of RP-A501 For The Treatment Of Danon Disease
By Business Wire
Dec 8, 2020 4:00 PM EST
PRESS RELEASES
Rocket Pharmaceuticals Presents Positive Clinical Data From Its Fanconi Anemia And Leukocyte Adhesion Deficiency-I Programs At The 62nd American Society Of Hematology Annual Meeting
By Business Wire
Dec 7, 2020 2:30 PM EST
PRESS RELEASES
Rocket Pharmaceuticals To Hold Webcast For Investors Highlighting Data Presented At The 62nd American Society Of Hematology Annual Meeting
By Business Wire
Dec 2, 2020 7:00 AM EST
PRESS RELEASES
Rocket Pharmaceuticals Receives Funding From The California Institute For Regenerative Medicine For Phase 1 Clinical Trial Of RP-L401 For Infantile Malignant Osteopetrosis
By Business Wire
Nov 13, 2020 7:00 AM EST
PRESS RELEASES
Rocket Pharmaceuticals To Present Data From Its Fanconi Anemia, Leukocyte Adhesion Deficiency-I And Pyruvate Kinase Deficiency Programs At The 62nd American Society Of Hematology Annual Meeting
By Business Wire
Nov 4, 2020 10:37 AM EST
PRESS RELEASES
Rocket Pharmaceuticals Announces Participation At Upcoming Conferences
By Business Wire
Sep 24, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Announces Participation At Upcoming Conferences
By Business Wire
Sep 4, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Announces First Patient Treated In Higher Dose Cohort In Phase 1 Clinical Trial Of RP-A501 For Danon Disease
By Business Wire
Sep 2, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Receives FDA Fast Track Designation For RP-L401 Gene Therapy For Infantile Malignant Osteopetrosis
By Business Wire
Aug 27, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Expands Clinical Sites For Its FA, Danon, LAD-I And IMO Trials, Adding To Its Global Centers Of Excellence
By Business Wire
Aug 26, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Announces First Patient Treated In Phase 1 Trial Of RP-L301 Gene Therapy For Pyruvate Kinase Deficiency
By Business Wire
Jul 13, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Announces FDA Clearance Of IND For RP-L401 Gene Therapy For Infantile Malignant Osteopetrosis
By Business Wire
Jun 29, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Announces Private Exchange Transaction Regarding Its Outstanding Convertible Senior Notes Due 2021
By Business Wire
Jun 8, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Announces Participation At The Jefferies Virtual Healthcare Conference
By Business Wire
May 26, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Presents Positive Updates On FA And LAD-I Gene Therapy Programs At The 23rd Annual Meeting Of The American Society Of Gene And Cell Therapy
By Business Wire
May 12, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Announces Participation At The BofA Securities 2020 Health Care Conference
By Business Wire
May 5, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Appoints Elisabeth Bjӧrk, M.D., Ph.D. To Board Of Directors
By Business Wire
Apr 22, 2020 7:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Provides Business Update In Light Of COVID-19 Pandemic
By Business Wire
Apr 2, 2020 9:00 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Announces Participation At The Guggenheim Healthcare Talks: Genomic Medicines And Rare Disease Day
By Business Wire
Apr 2, 2020 7:30 AM EDT
PRESS RELEASES
Rocket Pharmaceuticals Announces Science Translational Medicine Publication Of Its Program In Danon Disease
By Business Wire
Mar 19, 2020 7:00 AM EDT
